Perhaps it won’t be used at the level we’ve seen during COVID-19, but one thing is certain: Telehealth is here to stay. The question is, how can pharma organizations prepare for and adapt to the future of telehealth? We’ve made two predictions based on market analysis and the findings from several ZS surveys to both inform and assist pharma along the journey.
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
